The clinical information you need, at your fingertips.

Real-world chart review finds only 12% of men starting testosterone met key guideline-concordant diagnostic and safety criteria. . .

Starting a GLP-1 on top of two or more blood pressure medications was linked to a modest rise in fainting, dizziness and other hypotensive events, concentrated in older and diabetic patients. . .

A population-based study finds a sustained increase in type 1 diabetes incidence among adolescents aged 15–19 years in Puerto Rico from 2009 to 2024. . .

Semaglutide was tied to 15% fewer fractures than dulaglutide or other weight-loss drugs in adults with type 2 diabetes. That's even though it produced greater weight loss, which typically raises fracture risk. . .

Real-world OPTION-VMS data suggest fezolinetant may improve both VMS bother and mood symptoms. . .

The tocilizumab biosimilar now offers an additional treatment option for CAR T cell–induced CRS and certain hospitalized patients with severe COVID-19. . .